IOPtima Ltd. develops, manufactures and distributes novel surgical treatments for Glaucoma - The IOPtiMate™.
The IOPtiMate™ is an innovative surgical system performing non-invasive Filtration Surgery for Glaucoma patients.
As an alternative to conventional surgery, the IOPtiMate™ is designed to provide excessive non-penetrating, safe and simple solution to elevated intraocular pressure and by such reducing reliance on anti-Glaucoma drugs (eye drops).
As the IOPtiMate™ CO2 Laser Assisted Filtration Surgery is a non-penetrating filtration procedure; it significantly reduces the known risks of intra- and post-operative complications as well as the follow-up interventions commonly associated with penetrating surgical alternatives.
Key Benefits:
Minimally-invasive
Excellent safety profile
Long-term efficacy
Reduces reliance on drug compliance
Simple to perform, outpatient module
Reproducible results
The system is CE approved, is used and is commercially available in major Israeli and European medical centers as well as in S. American and the Far East.
